Carl G. Maki, PhD
Graduate Kansas State University, Biology Department, Manhattan, KS, USA
Carl Maki received his doctorate in Molecular Biology from Kansas State University and his doctoral thesis was to study the RPS17 ribosomal protein and its gene promoter. After graduation, he carried out postdoctoral studies at the National Institutes of Health in Bethesda, MD and at Harvard Medical School. He was hired as an Assistant Professor in Cancer Biology at the Harvard School of Public before moving to the University of Chicago in the Department of Radiation Oncology. He is currently an Associate Professor in Cell and Molecular Medicine at Rush University Medical Center in Chicago. Dr. Maki’s research has focused on two areas: 1) the P53 tumor suppressor and how the levels and activity of p53 are regulated, and 2) mechanisms of cancer chemotherapy resistance. He has authored or coauthored more than 50 peer reviewed papers and two book chapters in related fields.